Online activity and real-world sensors are generating torrents of data about everything from weather to crime to our buying habits. Increasing computer power and new analytical techniques promise to turn masses of raw data into actionable intelligence—and thereby transform a variety of industries. But the transformational potential of Big Data has hovered on the horizon for some time now. Has Big Data’s moment finally come? We will talk to experts in healthcare and marketing about the state of the Big Data revolution.
Sol Goldman Family Professor of Social and Natural Science
Nicholas A. Christakis, MD, PhD, MPH, is a sociologist and physician who conducts research in the areas of social networks and biosocial science. He directs the Human Nature Lab. His current research is mainly focused on two topics: (1) the...
Nicholas A. Christakis, MD, PhD, MPH, is a sociologist and physician who conducts research in the areas of social networks and biosocial science. He directs the Human Nature Lab. His current research is mainly focused on two topics: (1) the social, mathematical, and biological rules governing how social networks form (“connection”), and (2) the social and biological implications of how they operate to influence thoughts, feelings, and behaviors (“contagion”). His lab uses both observational and experimental methods to study these phenomena, exploiting techniques from sociology, computer science, biosocial science, demography, statistics, behavior genetics, evolutionary biology, epidemiology, and other fields. To the extent that diverse phenomena can spread within networks in intelligible ways, there are important policy implications since such spread can be exploited to improve the health or other desirable properties of groups (such as cooperation or innovation). Hence, current work in the lab involves conducting field experiments: some work involves the use of large-scale, online network experiments; other work involves large-scale randomized controlled trials in the developing world where networks are painstakingly mapped. Finally, some work in the lab examines the biological determinants and consequences of social interactions and related phenomena, with a particular emphasis on the genetic origins and evolutionary implications of social networks. The author of several books and over 150 articles, Christakis was elected to the Institute of Medicine of the National Academy of Sciences in 2006 and was made a Fellow of the American Association for the Advancement of Science in 2010.
Meagen Eisenberg '04
Chief Marketing Officer
Meagen has spent over 20 years working in the high-tech industry. One of Top 50 most retweeted by mid-sized marketers according to AdWeek study, 2015 most influential martech leaders and one of the Top 25 B2B Marketing Influencers according to...
Meagen has spent over 20 years working in the high-tech industry. One of Top 50 most retweeted by mid-sized marketers according to AdWeek study, 2015 most influential martech leaders and one of the Top 25 B2B Marketing Influencers according to InsideView. In 2014 she won the Marketers that Matter award, in 2012 she received the SuperNova Award in Matrix Commerce from Constellation Research and in 2011 the Marketing Visionary Markie award within the marketing automation field. Before joining MongoDB, she was VP of Demand Generation and Customer Marketing at DocuSign. Before DocuSign, she was Director of WW Demand Generation at ArcSight, an HP Company, and prior to that she led worldwide programs and events at TRIRIGA (acquired by IBM) for integrated workplace management systems. Prior to TRIRIGA, she was at Postini (acquired by Google) and IBM, working in solutions and product marketing for security and compliance. Earlier she worked as an IT Engineer at Cisco Systems and Applied Materials. She has a Master of Business Administration with a focus on marketing and strategy from Yale School of Management, and a Bachelor of Science degree in MIS with a minor in CSC from Cal Poly – San Luis Obispo.
Harold H. Hines, Jr. Professor of Medicine (Cardiology) and Professor in the Institute for Social and Policy Studies, of Investigative Medicine and of Public Health (Health Policy); Director, Center for Outcomes Research and Evaluation, Yale-New Haven Hos
Harlan Krumholz is a cardiologist, health care scientist, and health care improvement expert at Yale University where he is the Harold H. Hines, Jr. Professor of Medicine and Co-Director of the Robert Wood Johnson Foundation Clinical Scholars...
Harlan Krumholz is a cardiologist, health care scientist, and health care improvement expert at Yale University where he is the Harold H. Hines, Jr. Professor of Medicine and Co-Director of the Robert Wood Johnson Foundation Clinical Scholars Program. He is the Director of the Center for Outcomes Research and Evaluation (CORE) at Yale New Haven Health. He has led research and initiatives to improve the quality and outcomes of clinical decisions and health care delivery, reduce disparities, enable transparency in practice and research, and avoid wasteful practices. His team is guiding federal efforts to measure and promote health care value. Dr. Krumholz established the Yale Open Data Access Project to promote data sharing and open science. He founded the Yale CORE Big Data to Knowledge initiative, aimed to deliver novel methodological approaches and tools to generate meaningful knowledge from large, complex healthcare data collections. He is also a scientific director of largescale population-based and clinical projects in China with the National Center for Cardiovascular Diseases including the Million Persons Project, a precision medicine initiative. Dr. Krumholz founded Hugo, a mobile app to empower people with their health-related data, promoting the possibility of a consumer-mediated information platform. He is a founding member of the Board of Governors of the Patient-Centered Outcomes Research Institute and a member of the National Academy of Medicine, the American Society for Clinical Investigation, and the Association of American Physicians. Dr. Krumholz received a BS from Yale, an MD from Harvard Medical School, and a Masters in Health Policy and Management from the Harvard University School of Public Health.